Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity
Di Luzio, V.; Purcaro, A.; Curzi, G.; Di Segni, E.; Chiesa, R.; Di Giuseppe, F.
Bollettino Della Societa Italiana di Cardiologia 17(3): 179-187
1972
ISSN/ISBN: 0037-878X PMID: 4671753 Document Number: 44332
Document emailed within 1 workday
Related Documents
Erikssen, J.; Rod, T. 1971: Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 721-725Laubie, M.; Cheymol, G.; Mouillé, P.; Gilbert, J.C.; Schmitt, H. 1973: Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395) Archives Internationales de Pharmacodynamie et de Therapie 201(2): 323-333
Erina, E.V.; Charyev, K.E.; Oshchepkova, E.V. 1983: Therapeutic effect of the cardioselective beta-blocking agent tenormin and its action on the indices of systemic, intracardiac and regional hemodynamics in patients with hypertension Kardiologiia 23(4): 53-59
Mattioli, G.; Ricci, S.; Menozzi, A.; Teglio, V. 1982: Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies Minerva Cardioangiologica 30(3): 81-88
Rodrigues, R.; Kornfeld, J.; Pereira, E.M. 1972: Anti-arrhythmic effect of a new adrenergic beta receptor blocking substance Arquivos Brasileiros de Cardiologia 25(6): 471-475
Singh, B.N. 1973: Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias New Zealand Medical Journal 78(504): 482-486
Fossati, C. 1985: Collateral effects of an anti-arrhythmic agent: amiodarone La Clinica Terapeutica 114(6): 509-514
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Hara, Y.; Sato, E.; Miyagishi, A.; Aono, S.; Nakatani, H. 1979: Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 75(7): 707-720
Besse, P.; Terrasson, C.; Choussat, A.; Broustet, J.P.; Bricaud, H. 1971: Mechanical and contractile properties of human myocardium. II. Contractile properties of normal human cardiac muscle Archives des Maladies du Coeur et des Vaisseaux 64(4): 485-500
Ishii, M.; Komori, S.; Satoh, H.; Ohta, T.; Motomura, S.; Hashimoto, K. 1984: Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 84(3): 259-266
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Fujita, T.; Miyazaki, M. 1972: Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124 Masui. Japanese Journal of Anesthesiology 21(5): 450-457
Libersa, C.; Caron, J.; Guedon-Moreau, L.; Lacroix, D. 1992: Pro-arrhythmic effects of anti-arrhythmic agents. Study methods and difficulties in analysis Therapie 47(5): 363-365
Dufour, R.; Scazziga, B.; Schelling, J.L. 1970: Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(1): 145-147
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Goldstein, M.; Vincent, J.L.; D'Hollander, A.; Kahn, R.J.; De Smet, J.M.; Le Clerc, J.L. 1989: Absence of cardio-depressant effects of CGP 17582 B, a new beta-blocking agent, in patients after coronary surgery Acta Cardiologica 44(3): 229-234
Shibasaki, K.; Uchida, W.; Shirai, Y.; Inagaki, O.; Asano, M.; Takenaka, T. 1994: Pharmacological properties of YM-15430-1, a 1,4-dihydropyridine derivative with beta 1-adrenoceptor-blocking activity Archives Internationales de Pharmacodynamie et de Therapie 328(2): 213-224
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Lotto, A.; Finzi, A. 1986: Evaluation of the hemodynamic effects and anti-arrhythmic activity of propafenone: from new frontiers to clinical verification Giornale Italiano di Cardiologia 16(4): 333-335